<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title>All Insights - Quantisnow</title>
    <description>Every item on the wire - press releases, filings, ratings, everything.</description>
    <link>https://www.quantisnow.com/news/all-insights</link>
    <language>en-us</language>
    <lastBuildDate>Sat, 17 Oct 2026 17:22:53 GMT</lastBuildDate>
    <item>
      <title>JinkoSolar Unveils Tiger Neo 5.0 All-Black Residential Solar Module with 25.52% Efficiency</title>
      <description>SHANGRAO, China, Oct. 17, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (&quot;JinkoSolar&quot; or the &quot;Company&quot;) (NYSE:JKS), today unveiled Tiger Neo 5.0, an all-black residential solar module built on its all-new TAC technology. The first version to reach the market, an all-black 48-cell module, delivers a maximum power output of 510 W with a module efficiency of 25.52%. It was designed to redefine the upper limits of what a scenario-specific module can deliver in both appearance and efficiency for premium homes and other architecturally refined residences.
The module showcases a deeper, more uniform and more refined black appearance than conventional back-contact (BC) modules. Semiconductor-gra</description>
      <link>https://www.quantisnow.com/insight/jinkosolar-unveils-tiger-neo-50-all-black-residential-solar-module-with-6749719</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/jinkosolar-unveils-tiger-neo-50-all-black-residential-solar-module-with-6749719</guid>
      <pubDate>Sat, 17 Oct 2026 11:33:00 GMT</pubDate>
    </item>
    <item>
      <title>SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026</title>
      <description>20 scientific presentations underscore the breadth of AbbVie&apos;s leadership in Inflammatory Bowel Disease (IBD) research programsLatest long-term and real-world data with SKYRIZI®(risankizumab) and RINVOQ® (upadacitinib) provide additional insight into clinical and endoscopic outcomes over approximately three years in moderately to severely active Crohn&apos;s disease and ulcerative colitisNew data evaluating endoscopic remission with investigational dual-targeting therapy ABBV-466 in patients with moderate-to-severe Crohn&apos;s disease will also be presentedNORTH CHICAGO, Ill., Oct. 17, 2026 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced the presentation of 20 new scientific abstracts from its IBD</description>
      <link>https://www.quantisnow.com/insight/skyrizi-risankizumab-and-rinvoq-upadacitinib-data-highlight-long-term-clinical-and-6749718</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/skyrizi-risankizumab-and-rinvoq-upadacitinib-data-highlight-long-term-clinical-and-6749718</guid>
      <pubDate>Sat, 17 Oct 2026 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Ballard Announces Q3 2026 Results Conference Call</title>
      <description>VANCOUVER, BC, Oct. 16, 2026 /CNW/ -- Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) will hold a conference call on Monday November 16th, 2026 at 8:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to review third quarter 2026 operating results.
    
                
                    
                
    
The live call can be accessed by dialing +1-833-821-2814 (Canada/US toll free). Alternatively, a live webcast can be accessed through a link on Ballard&apos;s homepage (www.ballard.com), in the &apos;Latest News&apos; section or by clicking here: Q3 Webcast. Following the call, a link to the webcast will be available in the &apos;Investor Hub&apos; area of the &apos;Investors&apos; section of Ballard&apos;s website (www.ballard.</description>
      <link>https://www.quantisnow.com/insight/ballard-announces-q3-2026-results-conference-call-6749717</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/ballard-announces-q3-2026-results-conference-call-6749717</guid>
      <pubDate>Sat, 17 Oct 2026 02:30:00 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by ASP Isotopes Inc.</title>
      <description>4 - ASP Isotopes Inc. (0001921865) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-asp-isotopes-inc-6749716</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-asp-isotopes-inc-6749716</guid>
      <pubDate>Sat, 17 Oct 2026 01:57:56 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Skillz Inc.</title>
      <description>4 - Firy Inc. (0001801661) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-skillz-inc-6749715</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-skillz-inc-6749715</guid>
      <pubDate>Sat, 17 Oct 2026 01:56:48 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Skillz Inc.</title>
      <description>4 - Firy Inc. (0001801661) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-skillz-inc-6749714</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-skillz-inc-6749714</guid>
      <pubDate>Sat, 17 Oct 2026 01:56:20 GMT</pubDate>
    </item>
    <item>
      <title>Amendment: SEC Form SCHEDULE 13D/A filed by Hilltop Holdings Inc.</title>
      <description>SCHEDULE 13D/A - Hilltop Holdings Inc. (0001265131) (Subject)</description>
      <link>https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-hilltop-holdings-inc-6749713</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-hilltop-holdings-inc-6749713</guid>
      <pubDate>Sat, 17 Oct 2026 01:52:26 GMT</pubDate>
    </item>
    <item>
      <title>NIP Group Inc. Announces Results of Extraordinary General Meeting</title>
      <description>ABU DHABI, United Arab Emirates, Oct.  16, 2026  (GLOBE NEWSWIRE) -- NIP Group Inc. (&quot;NIP Group&quot; or the &quot;Company&quot;) (NASDAQ:NIPG), a leading digital entertainment company, today announced that the Company’s extraordinary general meeting of shareholders (the &quot;EGM&quot;) was held in Hong Kong on October 16, 2026. During the EGM, the following proposed resolutions were duly passed:  by a special resolution that, subject to the passing of Resolution 2, the Company’s authorized share capital be increased FROM US$200,000 divided into 2,000,000,000 shares comprising (i) 1,756,459,263 Class A ordinary shares of a par value of US$0.0001 each (the &quot;Class A Ordinary Shares&quot;), (ii) 148,331,658 Class B1 ordina</description>
      <link>https://www.quantisnow.com/insight/nip-group-inc-announces-results-of-extraordinary-general-meeting-6749712</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/nip-group-inc-announces-results-of-extraordinary-general-meeting-6749712</guid>
      <pubDate>Sat, 17 Oct 2026 01:55:00 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Vertical Aerospace Ltd.</title>
      <description>4 - Vertical Aerospace Ltd. (0001867102) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-vertical-aerospace-ltd-6749711</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-vertical-aerospace-ltd-6749711</guid>
      <pubDate>Sat, 17 Oct 2026 01:45:15 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by WhiteFiber Inc.</title>
      <description>4 - WhiteFiber, Inc. (0002042022) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-whitefiber-inc-6749710</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-whitefiber-inc-6749710</guid>
      <pubDate>Sat, 17 Oct 2026 01:42:41 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by WhiteFiber Inc.</title>
      <description>4 - WhiteFiber, Inc. (0002042022) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-whitefiber-inc-6749709</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-whitefiber-inc-6749709</guid>
      <pubDate>Sat, 17 Oct 2026 01:37:37 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by WhiteFiber Inc.</title>
      <description>4 - WhiteFiber, Inc. (0002042022) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-whitefiber-inc-6749708</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-whitefiber-inc-6749708</guid>
      <pubDate>Sat, 17 Oct 2026 01:36:50 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Natera Inc.</title>
      <description>4 - Natera, Inc. (0001604821) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-natera-inc-6749707</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-natera-inc-6749707</guid>
      <pubDate>Sat, 17 Oct 2026 01:35:08 GMT</pubDate>
    </item>
    <item>
      <title>Amendment: SEC Form SCHEDULE 13D/A filed by ALX Oncology Holdings Inc.</title>
      <description>SCHEDULE 13D/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)</description>
      <link>https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-alx-oncology-holdings-6749706</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-alx-oncology-holdings-6749706</guid>
      <pubDate>Sat, 17 Oct 2026 01:21:15 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by GrabAGun Digital Holdings Inc.</title>
      <description>4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-grabagun-digital-holdings-inc-6749705</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-grabagun-digital-holdings-inc-6749705</guid>
      <pubDate>Sat, 17 Oct 2026 01:20:01 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by GrabAGun Digital Holdings Inc.</title>
      <description>4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-grabagun-digital-holdings-inc-6749704</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-grabagun-digital-holdings-inc-6749704</guid>
      <pubDate>Sat, 17 Oct 2026 01:20:20 GMT</pubDate>
    </item>
    <item>
      <title>Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court</title>
      <description>Align Technology, Inc. (&quot;Align&quot;) (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court (&quot;UPC&quot;) finding that aligner systems incorporating Angelalign’s Torque Ridges feature infringe Align’s European Patent EP 2 237 738 B1, which relates to Align’s Power Ridge® technology.In August 2025, Align initiated patent infringement proceedings against several companies within the Angelalign Technology, Inc. corporate group (&quot;Angel&quot;) (Hong Kong Stock Exchange: 6699.HK) in multiple jurisdictions, including before the UPC, which covers participating European Union member stat</description>
      <link>https://www.quantisnow.com/insight/align-technology-wins-significant-patent-infringement-case-against-angelalign-at-6749703</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/align-technology-wins-significant-patent-infringement-case-against-angelalign-at-6749703</guid>
      <pubDate>Sat, 17 Oct 2026 01:11:00 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Moleculin Biotech Inc.</title>
      <description>4 - Moleculin Biotech, Inc. (0001659617) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-moleculin-biotech-inc-6749702</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-moleculin-biotech-inc-6749702</guid>
      <pubDate>Sat, 17 Oct 2026 01:01:05 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Moleculin Biotech Inc.</title>
      <description>4 - Moleculin Biotech, Inc. (0001659617) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-moleculin-biotech-inc-6749701</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-moleculin-biotech-inc-6749701</guid>
      <pubDate>Sat, 17 Oct 2026 01:00:43 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Moleculin Biotech Inc.</title>
      <description>4 - Moleculin Biotech, Inc. (0001659617) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-moleculin-biotech-inc-6749700</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-moleculin-biotech-inc-6749700</guid>
      <pubDate>Sat, 17 Oct 2026 01:00:18 GMT</pubDate>
    </item>
    <item>
      <title>Amendment: SEC Form SCHEDULE 13D/A filed by Clear Channel Outdoor Holdings Inc.</title>
      <description>SCHEDULE 13D/A - Clear Channel Outdoor Holdings, Inc. (0001334978) (Subject)</description>
      <link>https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-clear-channel-outdoor-6749699</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-clear-channel-outdoor-6749699</guid>
      <pubDate>Sat, 17 Oct 2026 00:53:30 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Clear Channel Outdoor Holdings Inc.</title>
      <description>4 - Clear Channel Outdoor Holdings, Inc. (0001334978) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-clear-channel-outdoor-holdings-inc-6749698</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-clear-channel-outdoor-holdings-inc-6749698</guid>
      <pubDate>Sat, 17 Oct 2026 00:48:51 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Grace Therapeutics Inc.</title>
      <description>4 - Grace Therapeutics, Inc. (0001444192) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-grace-therapeutics-inc-6749697</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-grace-therapeutics-inc-6749697</guid>
      <pubDate>Sat, 17 Oct 2026 00:42:41 GMT</pubDate>
    </item>
    <item>
      <title>Silver Pony Announces Strategic Offering of Units for up to $1,000,000 Including Significant Investor Doug Casey</title>
      <description>Vancouver, British Columbia--(Newsfile Corp. - October 16, 2026) - Silver Pony Resources Corp. (CSE:PONY) (FSE: BJ40) (OTCID: PONIF) (formerly Carlyle Commodities Corp.) (&quot;Silver Pony&quot; or the &quot;Company&quot;) is pleased to announce that it intends to complete a non-brokered private placement (the &quot;Offering&quot;) of up to 5,882,352 units (each, &quot;Unit&quot;) at a price of $0.17 per Unit for aggregate gross proceeds of up to $1,000,000.Each Unit will consist of one common share of the Company (a &quot;Share&quot;) and one transferable common share purchase warrant (a &quot;Warrant&quot;). Each Warrant will entitle the holder thereof to purchase one Share at a price of $0.30 per Share for a period of 36 months from the date of is</description>
      <link>https://www.quantisnow.com/insight/silver-pony-announces-strategic-offering-of-units-for-up-to-6749696</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/silver-pony-announces-strategic-offering-of-units-for-up-to-6749696</guid>
      <pubDate>Sat, 17 Oct 2026 00:42:00 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Xenon Pharmaceuticals Inc.</title>
      <description>4 - Xenon Pharmaceuticals Inc. (0001582313) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-xenon-pharmaceuticals-inc-6749695</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-xenon-pharmaceuticals-inc-6749695</guid>
      <pubDate>Sat, 17 Oct 2026 00:22:19 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Joint Stock Company Kaspi.kz</title>
      <description>4 - Joint Stock Co Kaspi.kz (0001985487) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-joint-stock-company-kaspikz-6749694</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-joint-stock-company-kaspikz-6749694</guid>
      <pubDate>Sat, 17 Oct 2026 00:20:43 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Beam Therapeutics Inc.</title>
      <description>4 - Beam Therapeutics Inc. (0001745999) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-beam-therapeutics-inc-6749693</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-beam-therapeutics-inc-6749693</guid>
      <pubDate>Sat, 17 Oct 2026 00:09:38 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by BJ&apos;s Restaurants Inc.</title>
      <description>4 - BJs RESTAURANTS INC (0001013488) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-bjs-restaurants-inc-6749692</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-bjs-restaurants-inc-6749692</guid>
      <pubDate>Sat, 17 Oct 2026 00:00:04 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by BJ&apos;s Restaurants Inc.</title>
      <description>4 - BJs RESTAURANTS INC (0001013488) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-bjs-restaurants-inc-6749691</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-bjs-restaurants-inc-6749691</guid>
      <pubDate>Sat, 17 Oct 2026 00:00:05 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by BJ&apos;s Restaurants Inc.</title>
      <description>4 - BJs RESTAURANTS INC (0001013488) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-bjs-restaurants-inc-6749690</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-bjs-restaurants-inc-6749690</guid>
      <pubDate>Sat, 17 Oct 2026 00:00:07 GMT</pubDate>
    </item>
    <item>
      <title>Amendment: SEC Form 4/A filed by CytomX Therapeutics Inc.</title>
      <description>4/A - CytomX Therapeutics, Inc. (0001501989) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/amendment-sec-form-4a-filed-by-cytomx-therapeutics-inc-6749689</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/amendment-sec-form-4a-filed-by-cytomx-therapeutics-inc-6749689</guid>
      <pubDate>Fri, 16 Oct 2026 23:40:15 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Penumbra Inc.</title>
      <description>4 - Penumbra Inc (0001321732) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-penumbra-inc-6749688</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-penumbra-inc-6749688</guid>
      <pubDate>Fri, 16 Oct 2026 23:36:01 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Nu Holdings Ltd.</title>
      <description>4 - Nu Holdings Ltd. (0001691493) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-nu-holdings-ltd-6749687</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-nu-holdings-ltd-6749687</guid>
      <pubDate>Fri, 16 Oct 2026 23:35:20 GMT</pubDate>
    </item>
    <item>
      <title>Blaize Holdings, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary</title>
      <description>SAN JOSE, Calif., Oct.  16, 2026  (GLOBE NEWSWIRE) -- Blaize Holdings, Inc. (NASDAQ:BZAI, NASDAQ:BZAIW) (&quot;Blaize,&quot; the &quot;Company,&quot; &quot;we,&quot; &quot;us,&quot; and &quot;our&quot;), a leader in programmable, energy-efficient AI computing, announced today that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series B Preferred Stock, par value $0.0001 per share, for each outstanding share of Blaize common stock held of record on October 26, 2026. The outstanding shares of Series B Preferred Stock will vote together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to any proposal to adopt an amendment to the Company’s certi</description>
      <link>https://www.quantisnow.com/insight/blaize-holdings-inc-announces-distribution-of-series-b-preferred-stock-6749686</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/blaize-holdings-inc-announces-distribution-of-series-b-preferred-stock-6749686</guid>
      <pubDate>Fri, 16 Oct 2026 23:30:00 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Adaptive Biotechnologies Corporation</title>
      <description>4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-adaptive-biotechnologies-corporation-6749685</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-adaptive-biotechnologies-corporation-6749685</guid>
      <pubDate>Fri, 16 Oct 2026 23:21:32 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by CleanCore Solutions Inc.</title>
      <description>4 - Zone Frontier Inc. (0001956741) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-cleancore-solutions-inc-6749684</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-cleancore-solutions-inc-6749684</guid>
      <pubDate>Fri, 16 Oct 2026 23:18:00 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749683</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749683</guid>
      <pubDate>Fri, 16 Oct 2026 23:16:29 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749682</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749682</guid>
      <pubDate>Fri, 16 Oct 2026 23:15:23 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749681</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749681</guid>
      <pubDate>Fri, 16 Oct 2026 23:14:11 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749680</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749680</guid>
      <pubDate>Fri, 16 Oct 2026 23:13:11 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749679</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749679</guid>
      <pubDate>Fri, 16 Oct 2026 23:12:20 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Suzano S.A.</title>
      <description>4 - Suzano S.A. (0000909327) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-suzano-sa-6749678</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-suzano-sa-6749678</guid>
      <pubDate>Fri, 16 Oct 2026 23:12:16 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749677</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749677</guid>
      <pubDate>Fri, 16 Oct 2026 23:11:17 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749676</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749676</guid>
      <pubDate>Fri, 16 Oct 2026 23:10:31 GMT</pubDate>
    </item>
    <item>
      <title>Amendment: SEC Form 4/A filed by Suzano S.A.</title>
      <description>4/A - Suzano S.A. (0000909327) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/amendment-sec-form-4a-filed-by-suzano-sa-6749675</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/amendment-sec-form-4a-filed-by-suzano-sa-6749675</guid>
      <pubDate>Fri, 16 Oct 2026 23:10:01 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749674</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749674</guid>
      <pubDate>Fri, 16 Oct 2026 23:09:43 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by FMC Corporation</title>
      <description>4 - FMC CORP (0000037785) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749673</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-fmc-corporation-6749673</guid>
      <pubDate>Fri, 16 Oct 2026 23:08:51 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Kratos Defense &amp; Security Solutions Inc.</title>
      <description>4 - KRATOS DEFENSE &amp; SECURITY SOLUTIONS, INC. (0001069258) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-kratos-defense-security-solutions-inc-6749672</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-kratos-defense-security-solutions-inc-6749672</guid>
      <pubDate>Fri, 16 Oct 2026 23:06:31 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by StandardAero Inc.</title>
      <description>4 - StandardAero, Inc. (0002025410) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-standardaero-inc-6749671</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-standardaero-inc-6749671</guid>
      <pubDate>Fri, 16 Oct 2026 23:02:33 GMT</pubDate>
    </item>
    <item>
      <title>SEC Form 4 filed by Grupo Aeromexico S.A.B. de C.V.</title>
      <description>4 - Grupo Aeromexico, S.A.B. de C.V. (0001561861) (Issuer)</description>
      <link>https://www.quantisnow.com/insight/sec-form-4-filed-by-grupo-aeromexico-sab-de-cv-6749670</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sec-form-4-filed-by-grupo-aeromexico-sab-de-cv-6749670</guid>
      <pubDate>Fri, 16 Oct 2026 23:00:24 GMT</pubDate>
    </item>
  </channel>
</rss>